| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2002046179A8 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 08/08/2002 | US20020107345 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | DE10104406A1 Verfahren zum katalytischen Erzeugen von organischen Stoffen durch partielle Oxidation A method for generating catalytic partial oxidation of organic matter by |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2435925A1 Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile |
| 08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | CA2434853A1 Chemical compounds |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/07/2002 | EP1229037A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
| 08/07/2002 | EP1229028A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
| 08/07/2002 | EP1229027A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228056A2 Method for the preparation of citalopram |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362410A Preparation method for butyrolactone |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/06/2002 | US6429321 Depolymerization of polytetrahydrofuran derivatives |
| 08/06/2002 | US6429319 Continuous process for the production of optically pure (S)-beta-hydroxy-gamma-butyrolactone |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/06/2002 | US6429203 Farnesyl-protein transferase inhibitors |
| 08/01/2002 | WO2002059165A2 Polymerization of olefinic compounds |
| 08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
| 08/01/2002 | WO2002059084A2 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
| 08/01/2002 | WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002058658A1 Primary intermediates for oxidative coloration of hair |
| 08/01/2002 | WO2002058631A2 Primary intermediates for oxidative coloration of hair |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001092247A3 Preparation of 4-hydroxy-3[2h]-furanones |
| 08/01/2002 | US20020103256 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | US20020103168 Fungicide phenylimine derivatives |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2434311A1 4-amino-2-(1-aryloxy-ethyl)phenol compounds as primary intermediates for oxydative coloration of hair |
| 08/01/2002 | CA2433686A1 Primary intermediates for oxidative coloration of hair |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/31/2002 | EP1227088A1 Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof |
| 07/31/2002 | EP1227077A2 Process for producing cyclopropanecarboxylates |
| 07/31/2002 | EP1226133A2 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
| 07/31/2002 | EP1226108A1 Diaryl-enynes |
| 07/31/2002 | EP1225883A1 Anti-ischemic compounds |
| 07/31/2002 | EP1042310B1 Method for the preparation of citalopram |
| 07/31/2002 | EP0824356B1 Pharmaceutical compositions for the treatment of alcohol addiction |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1361106A Corter pseudolaricis acetic acid derivative and its medicinal composite and their antineoplastic and antifungal application |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/30/2002 | US6426422 Method for the preparation of citalopram |
| 07/30/2002 | US6426417 Processes and intermediates useful to make antifolates |
| 07/30/2002 | US6426366 Pharmaceutical compositions comprising tyrphostins |
| 07/30/2002 | US6426365 CETP activity inhibitors |
| 07/30/2002 | US6426023 Benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (CO)polymer matrices containing them |
| 07/30/2002 | CA2291067C Method for the preparation of citalopram |
| 07/30/2002 | CA2148683C Potentiator of bacillus pesticidal activity |
| 07/30/2002 | CA2104461C Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 07/25/2002 | WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/25/2002 | WO2002057249A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057248A2 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057247A2 Addition of mineral acids or salts thereof to a trimellitic acid anhydride production process |
| 07/25/2002 | WO2002057246A2 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057224A2 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
| 07/25/2002 | WO2002057219A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 07/25/2002 | WO2002057216A1 Terphenyl compounds bearing substituted amino groups |
| 07/25/2002 | WO2002038107A3 Stat modulators |
| 07/25/2002 | WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2001098238A3 Catalytic hydrogenation of ketones and aldehydes |
| 07/25/2002 | WO2001092273A3 Benzenedicarboxylic acid derivatives |
| 07/25/2002 | WO2001072732A3 Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan |